$24.98
+0.00%
N/A+$0.00
헬스케어
생명공학
NASDAQ
비활성
XOMA Royalty Corporation은 미국, 스위스, 아시아 태평양 및 호주에서 활동하는 생명공학 로열티 통합 기업입니다. 이 회사는 상업용 제품 및 상업화 전 단계의 ...
XOMA Royalty Corporation은 미국, 스위스, 아시아 태평양 및 호주에서 활동하는 생명공학 로열티 통합 기업입니다. 이 회사는 상업용 제품 및 상업화 전 단계의 ...
XOMA Royalty Corporation operates as a specialized biotech royalty aggregator. Unlike traditional pharmaceutical firms that conduct direct R&D, XOMA acquires and manages economic interests in the intellectual property of third-party biotech and pharmaceutical developers. Its portfolio consists of over 120 assets, ranging from pre-commercial clinical candidates (primarily Phase 1 and 2) to commercial-stage therapies, entitling the company to a share of future revenues and regulatory milestone payments generated by these products.
가격대: N/A (Financial instrument/Asset Portfolio)
페인 포인트: Solves the liquidity and capital constraints faced by biotech companies during the long, costly clinical development cycle by providing upfront capital in exchange for future royalty streams.
솔루션: Provides non-dilutive capital to biotech partners and offers investors a diversified exposure to the biotechnology sector while mitigating the risk associated with individual drug development failures.
대상 사용자: Biotechnology and pharmaceutical companies in need of non-dilutive capital; Institutional and retail investors seeking exposure to the pharma/biotech industry.